Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Tampa › NPI 1790732360
Physician

Ruffolo Hooper & Associates MD PA

Ruffolo Hooper & Associates MD PA was paid $9.86M by Medicaid between Jan 2018 and Dec 2024, across 277 billing codes. Its largest line is 85025, Blood count; complete (CBC), automated, and automated differential WBC count — 14% of everything it billed.

33Billing provider infoRUFFOLO HOOPER & ASSOCIATES MD PA
TAMPA, FL 33634
33aNPI1790732360assigned 05/28/2006
33bProvider typeCytopathology Physician
28Total paid$9.86M
24GClaims5,471,733
24DCodes billed277
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Cytopathology Physician providers in Florida

Rank by total paid#2 of 14
Median peer was paid$776K
This provider vs. median13×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018290,215$173K
2019713,448$2.00M
2020779,754$1.67M
2021840,140$1.52M
20221,246,408$1.34M
2023951,458$2.02M
2024incomplete650,310$1.12M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
85025 Blood count; complete (CBC), automated, and automated differential WBC count 14% 809,087 320,413 $1.38M
88305 Level IV - Surgical pathology, gross and microscopic examination 12% 33,996 26,859 $1.20M
80053 Comprehensive metabolic panel 9.1% 484,500 263,704 $897K
88307 6.5% 14,499 11,830 $636K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 3.9% 18,848 14,718 $386K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 2.5% 11,832 10,660 $247K
80048 Basic metabolic panel (calcium, ionized) 2.5% 240,292 79,236 $247K
82805 2.3% 30,726 14,176 $229K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 2.2% 42,075 32,807 $213K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 2.0% 30,086 25,535 $192K
82803 1.9% 58,479 24,918 $188K
83735 1.8% 298,914 83,687 $174K
265 more codes
84484 1.6% 167,705 $159K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 1.6% 22,969 $156K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 1.6% 19,418 $154K
87641 1.5% 29,232 $148K
81001 1.5% 214,034 $145K
83605 1.4% 121,145 $139K
81025 1.2% 74,452 $113K
87040 1.1% 79,172 $113K
85027 <1% 117,487 $94K
83880 <1% 46,842 $94K
84703 <1% 110,014 $93K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 32,657 $81K
83690 <1% 113,094 $73K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 25,647 $72K
82330 <1% 42,837 $70K
84443 Thyroid stimulating hormone (TSH) <1% 38,742 $64K
88342 <1% 8,041 $63K
87631 <1% 5,204 $59K
87086 Culture, bacterial; quantitative colony count, urine <1% 63,716 $59K
85610 <1% 128,442 $58K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 9,565 $56K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 25,685 $54K
82947 <1% 112,692 $50K
84702 <1% 34,192 $49K
87077 <1% 33,427 $47K
84100 <1% 125,379 $46K
85730 <1% 95,736 $44K
83036 Hemoglobin; glycosylated (A1C) <1% 39,396 $42K
87070 <1% 34,671 $38K
87400 <1% 21,403 $37K
80321 <1% 15,062 $34K
86803 <1% 21,638 $33K
81003 <1% 81,213 $32K
85390 <1% 4,565 $30K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 9,969 $30K
82607 <1% 16,221 $29K
86900 <1% 49,799 $28K
80202 <1% 17,795 $28K
87430 <1% 10,683 $28K
86850 <1% 29,925 $27K
80329 <1% 4,075 $25K
82550 <1% 35,737 $25K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 9,789 $24K
86708 <1% 23,645 $24K
87653 <1% 5,046 $23K
85379 <1% 29,001 $23K
82247 <1% 52,734 $23K
82728 <1% 23,904 $22K
86141 <1% 21,991 $22K
87186 <1% 31,762 $22K
86901 <1% 50,231 $21K
82553 <1% 4,899 $21K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 4,123 $20K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 7,560 $19K
88304 <1% 1,776 $18K
83970 <1% 2,948 $18K
82375 <1% 23,433 $18K
85520 <1% 18,771 $18K
87420 <1% 6,078 $17K
80069 <1% 19,169 $16K
80197 <1% 11,906 $16K
80061 Lipid panel <1% 10,980 $15K
82570 <1% 20,584 $15K
87507 <1% 1,637 $15K
87340 <1% 15,544 $14K
82150 <1% 5,110 $14K
85576 <1% 6,609 $13K
87807 <1% 2,894 $13K
85384 <1% 18,135 $13K
82248 <1% 26,753 $13K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,590 $13K
86140 <1% 24,990 $13K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 26,129 $13K
87496 <1% 3,170 $12K
87205 <1% 21,174 $12K
82746 <1% 12,139 $12K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 4,120 $11K
88189 <1% 463 $11K
83615 <1% 24,798 $11K
85055 <1% 7,287 $11K
85007 <1% 28,535 $11K
87210 <1% 21,091 $11K
87497 <1% 2,641 $11K
84439 <1% 12,344 $10K
82140 <1% 6,225 $10K
87799 <1% 978 $10K
85014 <1% 33,531 $10K
87522 Neg quan hep c or qual rna <1% 2,694 $9K
86480 <1% 2,451 $9K
87529 <1% 2,914 $9K
87102 <1% 4,422 $9K
87081 <1% 10,068 $8K
87899 <1% 1,623 $8K
83550 <1% 12,294 $7K
85046 <1% 17,478 $7K
84145 <1% 31,650 $7K
80074 <1% 1,392 $7K
87486 <1% 930 $6K
85652 <1% 19,929 $6K
82010 <1% 3,969 $6K
84134 <1% 5,459 $6K
82105 <1% 2,094 $6K
85018 <1% 23,913 $6K
82948 <1% 7,578 $6K
83540 <1% 14,192 $6K
86704 <1% 4,941 $5K
86762 <1% 3,624 $5K
86769 <1% 1,094 $5K
82533 <1% 3,181 $5K
84156 <1% 16,522 $5K
87481 <1% 1,562 $5K
84478 <1% 7,293 $5K
85060 <1% 628 $5K
84550 <1% 11,373 $5K
86880 <1% 12,444 $5K
87116 <1% 4,233 $5K
88112 <1% 375 $5K
86665 <1% 915 $4K
84311 <1% 6,246 $4K
86706 <1% 5,362 $4K
87536 <1% 938 $4K
85347 <1% 6,878 $4K
86304 <1% 1,044 $4K
84300 <1% 6,173 $4K
83050 <1% 11,316 $4K
87206 <1% 3,391 $4K
88341 <1% 195 $3K
88302 <1% 236 $3K
89051 <1% 4,703 $3K
80076 <1% 4,823 $3K
83020 <1% 1,361 $3K
82784 <1% 3,036 $3K
82962 <1% 6,533 $3K
88312 <1% 722 $3K
87428 <1% 396 $3K
83010 <1% 2,535 $3K
83930 <1% 3,778 $3K
82077 <1% 9,278 $3K
84112 <1% 504 $3K
87015 <1% 4,068 $3K
84165 <1% 1,353 $2K
86592 <1% 5,584 $2K
86038 <1% 2,494 $2K
87449 <1% 2,322 $2K
82378 <1% 1,084 $2K
80164 <1% 1,030 $2K
87075 <1% 2,746 $2K
87581 <1% 933 $2K
86160 <1% 780 $2K
80050 General health panel <1% 1,925 $2K
84295 <1% 3,357 $2K
87517 <1% 581 $2K
86147 <1% 446 $2K
83935 <1% 3,070 $2K
86780 <1% 2,478 $2K
86644 <1% 935 $2K
84466 <1% 1,398 $2K
84132 <1% 3,816 $2K
82945 <1% 2,106 $1K
85380 <1% 1,662 $1K
85045 <1% 3,952 $1K
87147 <1% 2,768 $1K
85049 <1% 2,015 $1K
84133 <1% 3,905 $1K
86361 <1% 756 $1K
86593 <1% 1,977 $1K
82436 <1% 3,895 $1K
87556 <1% 295 $1K
85651 <1% 2,839 $1K
80051 <1% 1,879 $1K
84157 <1% 3,094 $1K
84481 <1% 663 $970.35
86787 <1% 711 $921.43
88313 <1% 161 $916.09
82435 <1% 3,895 $877.01
86308 <1% 1,303 $875.48
84460 <1% 1,570 $822.33
84480 <1% 912 $815.46
86695 <1% 560 $755.68
80320 <1% 184 $731.75
87324 <1% 1,263 $701.54
83718 <1% 759 $692.12
86920 <1% 327 $660.77
82977 <1% 1,343 $653.76
86777 <1% 634 $609.12
86923 <1% 4,504 $532.58
87088 <1% 931 $470.43
82043 <1% 2,200 $466.16
87806 <1% 94 $453.27
86225 <1% 201 $430.23
86301 <1% 97 $420.98
38222 <1% 30 $420.37
82565 <1% 908 $408.53
84999 <1% 53 $354.83
86334 <1% 199 $338.65
87532 <1% 116 $336.34
86790 <1% 688 $336.34
86735 <1% 357 $330.90
87551 <1% 79 $297.00
86765 <1% 289 $262.02
84160 <1% 792 $242.99
83051 <1% 674 $240.67
87808 <1% 478 $235.94
84436 <1% 445 $219.05
88300 <1% 17 $219.00
83520 <1% 351 $203.50
83874 <1% 124 $199.58
84166 <1% 107 $198.11
82040 <1% 228 $194.59
87498 <1% 119 $186.20
82950 <1% 380 $182.09
87150 <1% 2,397 $169.01
87158 <1% 185 $160.88
87561 <1% 75 $158.25
88108 <1% 17 $156.47
82042 <1% 366 $150.41
84153 <1% 114 $143.26
87149 <1% 165 $138.78
86431 <1% 302 $138.44
83883 <1% 99 $134.81
87184 <1% 180 $126.05
82272 <1% 469 $119.25
86235 <1% 23 $115.28
86317 <1% 40 $114.04
87076 <1% 49 $111.70
82270 <1% 384 $110.68
89190 <1% 12 $74.42
84146 <1% 27 $74.18
83525 <1% 27 $71.67
86870 <1% 141 $69.70
80143 <1% 316 $61.64
80179 <1% 658 $55.57
86738 <1% 44 $49.62
87176 <1% 121 $49.27
82785 <1% 14 $49.21
87045 <1% 92 $39.58
82390 <1% 96 $35.78
86300 <1% 13 $33.64
86003 <1% 51 $30.21
84540 <1% 126 $27.22
80185 <1% 17 $26.54
85008 <1% 65 $25.59
80170 <1% 19 $21.96
82274 <1% 60 $21.96
86705 <1% 28 $21.42
80305 <1% 102 $20.72
86039 <1% 14 $20.42
82438 <1% 31 $14.49
87329 <1% 15 $13.34
86645 <1% 14 $11.25
87071 <1% 14 $9.88
84155 <1% 26 $9.16
87046 <1% 78 $6.24
80047 <1% 12 $4.04
87181 <1% 13 $3.38
87328 <1% 15 $1.86
84520 <1% 14 $1.14
81002 <1% 30 $0.84
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 0% 242 $0.00
87500 0% 24 $0.00
88350 0% 30 $0.00
88348 0% 15 $0.00
83521 0% 19 $0.00
83529 0% 17 $0.00
88346 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPALMA, KIM (ACCOUNT MANAGER)
Same official

Other billing entities under PALMA, KIM

Full network →
ProviderLocationPaid
Reliance Pathology Partners, LLCTampa, FL$2K
Patricia a Gregg, M.D., P.L.Lehigh Acres, FL$241.74

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.